论文部分内容阅读
治疗上、下呼吸道和喉部乳头状瘤病56例,年龄<1岁4例,1～5岁23例,5～7岁17例,>7岁12例。播散型乳头状瘤病25例(44.6％),其中13例已作气管造口术。复发间隔期3周至3月。细胞免疫检查.T淋巴细胞水平降低,辅助性T细胞减少,认为和病毒感染有关。 切除乳头状瘤手术后第二天,开始用Reaferon(α_2-干扰素)治疗。剂量:患儿<3岁不超过1.5×10~5IU/d,3～5岁1.5～2×10~5IU/d,>5岁2.5～3×10~5IU/d,重症3×10~5IU/d。 给药方法 1988年以前实行肌肉注射.4～6次时有36％的病例出现发热反应(38℃～50℃),37％出现
There were 56 cases of upper and lower respiratory tract and laryngeal papillomatosis. There were 4 patients <1 year old, 23 cases 1 to 5 years old, 17 cases 5 to 7 years old and 12 cases> 7 years old. Disseminated papilloma in 25 cases (44.6%), of which 13 cases have been tracheostomy. Recurrence interval of 3 weeks to March. Cellular immunity test.T lymphocyte levels decreased, helper T cells decreased, and that the virus infection. The next day after the resection of papilloma, treatment with Reaferon (alpha 2-interferon) started. Dosage: The patients ≤3 years old did not exceed 1.5 × 10 ~ 5IU / d, 3 ~ 5 years old 1.5 ~ 2 × 10 ~ 5IU / d,> 5 years old 2.5 ~ 3 × 10 ~ 5IU / d, severe 3 × 10 ~ 5IU / d. Method of administration Intramuscular injection was performed before 1988. Thirty-six percent (36%) of patients experienced fever (38 ° C to 50 ° C) at 4 to 6 times and 37%